PTA Balloon Catheter Market Forecasts 2019-2025
In 2018, the global PTA Balloon Catheter Market was worth USD 2.4 billion, and it is predicted to grow at a CAGR of 10.1 percent over the forecast period. The rising frequency of cardiovascular illnesses and peripheral artery disease, as well as the growing elderly population and the growing number of minimally invasive operations, are all contributing to the market's growth.
In the last three decades, cardiovascular disorders have surpassed cancer as the top cause of mortality worldwide. Sedentary behaviour is one of the leading causes of chronic diseases such as diabetes and cardiovascular disease. Obesity has become more prevalent as a result of harmful habits such as lack of physical activity, intake of alcohol and unhealthy foods, and smoking, which in turn, leads to various cardiovascular diseases. The need for percutaneous transluminal angioplasty (PTA) balloon catheters has increased as a result of surgical intervention for the treatment of such illnesses. Peripheral Artery Disease (PAD) affects more than 200 million people worldwide, according to a study published by the National Center for Biotechnology Information in 2018 Individuals with PAD are more likely to develop significant cardiac issues later in life. The usage of the PTA Balloon Catheter is predicted to increase as hospitalisation rates rise along with an increase in cardiovascular illnesses.
PAD is generally treated with catheters to open clogged arteries, which is a minimally invasive procedure. Patients are increasingly choosing angioplasty over traditional operations because of its minimally invasive nature and better outcomes. The number of catheterization laboratories has increased as a result of minimally invasive procedures.The most common minimally invasive technique recommended by PAD patients is peripheral angioplasty. These operations are carried under under local anaesthetic in a cardiovascular catheterization laboratory. Sales of catheters, particularly PTA variations, have increased as the paradigm change from traditional procedures to angioplasty has occurred.Because of the utilisation of sophisticated technologies and the availability of revolutionary coated PTA Balloon Catheters on the market, these procedures have a higher adoption rate and are becoming conventional techniques in general surgery.
Catheters, on the other hand, are frequently linked to vein thrombosis, which can lead to pulmonary embolism and, in some situations, death.A fibrin sheath surrounding the intraluminal, venous, mural thrombosis at the catheter tip can prevent thrombosis from obstructing the catheter. Due to the repeated use of catheters, patients who have cardiac catheterization are at an increased risk of catheter-associated bloodstream infections.Myocardial infarction, pseudoaneurysm, arteriovenous fistula, hematoma/retroperitoneal bleeding, thrombosis and embolism, and allergic reactions are among the major risks associated with cardiac catheterization, according to a study published by the National Center for Biotechnology Information in 2018. As a result, the risks and difficulties connected with catheters may limit the market for PTA Balloon Catheters' growth. However, they can be overcome with technological advancements.
Comments
Post a Comment